نبذة مختصرة : Head-to-head comparison of available commercial antibodies against Angiogenin by immunoblot (Western blot) and immunoprecipitation on culture media. The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported by the ALS-Reproducible Antibody Platform (ALS-RAP), a public-private partnership established by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
No Comments.